Glaukos Cash on Hand 2014-2026 | GKOS

Glaukos cash on hand from 2014 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Glaukos cash on hand for the quarter ending March 31, 2026 was $0.279B, a 12.59% decline year-over-year.
  • Glaukos cash on hand for 2025 was $0.279B, a 12.59% decline from 2024.
  • Glaukos cash on hand for 2024 was $0.319B, a 7.95% increase from 2023.
  • Glaukos cash on hand for 2023 was $0.295B, a 16.24% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Glaukos Annual Cash on Hand
(Millions of US $)
2025 $279
2024 $319
2023 $295
2022 $353
2021 $414
2020 $404
2019 $174
2018 $140
2017 $119
2016 $96
2015 $91
2014 $2
2013 $7
Glaukos Quarterly Cash on Hand
(Millions of US $)
2025-12-31 $279
2025-09-30 $274
2025-06-30 $275
2025-03-31 $299
2024-12-31 $319
2024-09-30 $262
2024-06-30 $262
2024-03-31 $273
2023-12-31 $295
2023-09-30 $301
2023-06-30 $304
2023-03-31 $318
2022-12-31 $353
2022-09-30 $362
2022-06-30 $391
2022-03-31 $415
2021-12-31 $414
2021-09-30 $429
2021-06-30 $419
2021-03-31 $407
2020-12-31 $404
2020-09-30 $388
2020-06-30 $395
2020-03-31 $164
2019-12-31 $174
2019-09-30 $153
2019-06-30 $150
2019-03-31 $145
2018-12-31 $140
2018-09-30 $138
2018-06-30 $120
2018-03-31 $114
2017-12-31 $119
2017-09-30 $109
2017-06-30 $104
2017-03-31 $99
2016-12-31 $96
2016-09-30 $94
2016-06-30 $94
2016-03-31 $88
2015-12-31 $91
2015-09-30 $93
2015-06-30 $104
2015-03-31 $4
2014-12-31 $2
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $7
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.760B $0.507B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $184.365B 21.69
Intuitive Surgical (ISRG) United States $160.029B 61.73
Edwards Lifesciences (EW) United States $44.895B 30.42
IDEXX Laboratories (IDXX) United States $44.716B 43.08
Alcon (ALC) Switzerland $38.585B 25.49
Waters (WAT) United States $31.413B 24.37
IQVIA Holdings (IQV) United States $28.398B 15.40
Mettler-Toledo (MTD) United States $26.829B 30.97
DexCom (DXCM) United States $24.639B 30.63
STERIS (STE) Ireland $21.830B 22.08
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $15.055B 23.03
SONOVA HOLDING (SONVY) Switzerland $13.774B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.199B 9.72
Penumbra (PEN) United States $12.941B 85.88
Globus Medical (GMED) United States $12.230B 22.60
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $6.754B 39.22
Sysmex ADR (SSMXY) Japan $5.470B 18.10
Teleflex (TFX) United States $5.233B 9.67
TransMedics (TMDX) United States $3.910B 40.00
LivaNova (LIVN) United Kingdom $3.433B 18.41
Integer Holdings (ITGR) United States $2.900B 13.28
Veracyte (VCYT) United States $2.470B 24.48
Elekta AB (EKTAY) Sweden $2.226B 20.13
Artivion (AORT) United States $1.825B 59.73
AxoGen (AXGN) United States $1.659B 0.00
Alphatec Holdings (ATEC) United States $1.650B 0.00
Nihon Kohden (NHNKY) Japan $1.642B 18.12
UFP Technologies (UFPT) United States $1.552B 20.54
Tandem Diabetes Care (TNDM) United States $1.314B 0.00
PROCEPT BioRobotics (PRCT) United States $1.308B 0.00
Pulse Biosciences (PLSE) United States $1.269B 0.00
IRadimed (IRMD) United States $1.194B 53.37
OPKO Health (OPK) United States $0.881B 0.00
Integra LifeSciences Holdings (IART) United States $0.772B 4.44
AVANOS MEDICAL, INC (AVNS) United States $0.659B 15.09
Alpha Tau Medical (DRTS) Israel $0.618B 0.00
SiBone (SIBN) United States $0.567B 0.00
Anteris Technologies Global (AVR) Australia $0.552B 0.00
Tactile Systems Technology (TCMD) United States $0.533B 28.23
Mesa Laboratories (MLAB) United States $0.530B 13.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.497B 0.00
NeuroPace (NPCE) United States $0.480B 0.00
AngioDynamics (ANGO) United States $0.405B 0.00
Pacific Biosciences Of California (PACB) United States $0.405B 0.00
OrthoPediatrics (KIDS) United States $0.404B 0.00
Beta Bionics (BBNX) United States $0.393B 0.00
Delcath Systems (DCTH) United States $0.346B 143.43
Semler Scientific (SMLR) United States $0.311B 2.32
Spectral Diagnostics (EDTXF) Canada $0.296B 0.00
RxSight (RXST) United States $0.282B 0.00
908 Devices (MASS) United States $0.267B 0.00
ClearPoint Neuro (CLPT) United States $0.257B 0.00
Lucid Diagnostics (LUCD) United States $0.203B 0.00
CVRx (CVRX) United States $0.188B 0.00
Sight Sciences (SGHT) United States $0.186B 0.00
Microbot Medical (MBOT) United States $0.174B 0.00
Inogen (INGN) United States $0.172B 0.00
Nano-X Imaging (NNOX) Israel $0.148B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Hyperfine (HYPR) United States $0.119B 0.00
Treace Medical Concepts (TMCI) United States $0.117B 0.00
Zomedica (ZOMDF) United States $0.111B 0.00
Solana (HSDT) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.096B 0.00
Neuronetics (STIM) United States $0.094B 0.00
QT Imaging Holdings (QTI) United States $0.083B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.074B 0.00
LENSAR (LNSR) United States $0.069B 0.00
Positron (POSC) United States $0.062B 0.00
InspireMD (NSPR) United States $0.060B 0.00
Spectral AI (MDAI) United States $0.055B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.047B 0.00
Accuray (ARAY) United States $0.046B 0.00
Atossa Genetics (ATOS) United States $0.043B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.028B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
NexGel (NXGL) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENvue Medical (FEED) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00